UroGen Pharma Kurtosis vs. Day Typical Price

URGN Stock  USD 9.27  0.19  2.01%   
UroGen Pharma technical analysis lookup allows you to check this and other technical indicators for UroGen Pharma or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
UroGen Pharma has current Kurtosis of 0.215. Kurtosis is a measure of the return distribution. In a similar way to the concept of skewness, kurtosis is a descriptor of the shape of a return distribution. There are various interpretations of kurtosis, and of how particular measures should be interpreted; these are primarily peakedness (width of peak), tail weight, and lack of shoulders (distribution primarily peak and tails, not in between).

Kurtosis

 = 

4PM

STD4

 = 
0.215
4PM = Forth upper moment
STD =   Standard Deviation of UroGen Pharma

UroGen Pharma Kurtosis Peers Comparison

1.670.220.000.460.00100%
A high kurtosis typically shows a distribution of returns with fat tails, whereas a low kurtosis portrays a distribution with skinny tails or a distribution concentrated toward the mean.
Compare UroGen Pharma to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Assets

XLO
Xilio Development
0.91  0.02  2.25 
VIGL
Vigil Neuroscience
2.42  -0.05  -2.02 
INBX
Inhibrx
13.25  0.65  5.16 
IKNA
Ikena Oncology
1.34  -0.03  -2.19 
CNTB
Connect Biopharma
0.91  0.01  1.11 
SRRK
Scholar Rock Holding
38.82  2.86  7.95 
MACK
Merrimack Pharmaceuticals
0.00  0.00  0.00 
TYRA
Tyra Biosciences
11.71  -0.01  -0.09 
CMPX
Compass Therapeutics
2.90  -0.02  -0.68 
VACC
Vaccibody As
0.00  0.00  0.00 
EWTX
Edgewise Therapeutics
26.17  -0.22  -0.83 
GBIO
Generation Bio
0.58  0.04  7.41 
ELVN
Enliven Therapeutics
20.83  0.68  3.37 
TARA
Protara Therapeutics
3.74  0.35  10.32 
OVID
Ovid Therapeutics
0.53  -0.01  -1.85 
ELYM
ELYM Old
0.00  0.00  0.00 
KRON
Kronos Bio
0.98  0.02  2.08 
PEPG
PepGen
3.15  0.72  29.63 
PRTC
PureTech Health PLC
17.80  -1.09  -5.77 
CCCC
C4 Therapeutics
2.71  0.11  4.23